Carcinoma, Transitional Cell - 25 Studies Found Completed : Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy : Urothelial Carcinoma : 2011-08-31 : Drug: Cabazitaxel Completed : Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With Cabazitaxel : Transitional Cell Carcinoma : 2012-08-13 : Drug: Cabazitaxel 25 mg/m2, IV Active, not recruiting : Bacillus Calmette-Guerin Followed by Sunitinib for the Treatment of High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma : Urinary Tract Urothelial Carcinoma : 2008-11-20 : Drug: Sunitinib Patients are treated with a 6-week inducti Active, not recruiting : DNA Methylation and Urothelial Carcinoma : Urothelial Carcinoma : 2011-06-20 Active, not recruiting : EGCG Modulate the Cytotoxic Effects of Chemotherapeutic Agents in Human Urothelial Carcinoma Cells : Urothelial Carcinoma : 2013-10-24 Active, not recruiting : The Role of Pyruvate Kinase M2 in Growth, Invasion and Drug Resistance in Human Urothelial Carcinoma : Bladder Urothelial Carcinoma : 2013-10-21 Completed : DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma : Urothelial Carcinoma : 2011-05-04 : Biological: DN24-02 DN24-02 is Completed : Arsenic Methylation Enzymes, Cigarette Metabolites, DNA Repair Enzymes, Inflammatory Factors and Urothelial Carcinoma : Urothelial Carcinoma : 2009-03-01 Active, not recruiting : Neoadjuvant Erlotinib (Tarceva) in Transitional Cell Carcinoma : Transitional Cell Carcinoma : 2008-09-05 : Drug: Erlotinib Hydrochloride 150 mg (pill) by mouth daily for 3 to 5 weeks prior to surgery Completed : Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma : Urothelial Carcinoma : 2016-06-17 : Drug: Atezolizumab Atezolizuma <<< Previous | Next >>>
